MedTrace Logo

Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement

NCT04367350 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-04-29

No results posted yet for this study

Summary

Prospective registry for multimodal assessment of neuromuscular pathology associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, enrolling consecutive patients with corona virus disease 2019 (Covid-19), who are admitted to the intensive care unit of the department of anesthesiology and intensive care medicine, or the department of neurology at Tübingen University Hospital.

Conditions

Interventions

DIAGNOSTIC_TEST

laboratory biomarkers

creatine kinase, troponin, urine myoglobin, and autoimmune antibodies

DIAGNOSTIC_TEST

muscle ultrasound

Muscle echogenicity in the upper and lower extremities, the accessory respiratory serratus anterior muscle, and abdominal wall according to qualitative ultrasound assessment (Heckmatt score)

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-20
Primary Completion
2021-03-31
Completion
2022-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04367350 on ClinicalTrials.gov